Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a video workout keep pregnant women moving more than a gym class?

NCT ID NCT06585085

Prevention Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Researchers in Clermont-Ferrand, France, are testing which type of exercise program helps pregnant women stick with physical activity and sit less. Women join one of several groups: weekly in-person sessions, live video sessions, or a mix of both. The study measures how much they move and how much time they spend sedentary using a hip accelerometer during the second trimester. The goal is to find the format that best supports an active pregnancy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured physical activity programs delivered in person, by videoconference, or a mix of both
What this could lead to
If one format works best, it could shape how prenatal care programs help pregnant women stay active and sit less, which may support healthier pregnancies.
What could go wrong
This trial measures activity levels with hip accelerometers, not pregnancy outcomes, so any benefit to mothers or babies remains unproven. Pregnant women may find it hard to attend sessions or stick with the program, and results from one French city may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 654 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women of more of 18 years and who are being monitored for pregnancy in the Clermont-Ferrand metropolitan area, * Planned to give birth in a maternity unit localized in Clermont-Ferrand metropolitan area (CHU Estaing or Clinique de la Chataigneraie), * Agreeing to be randomized, to follow the physical activity program offered in the Clermont-Ferrand metropolitan area, and to follow up as part of the study, * Able to give informed consent to participate in the research, * Affiliated to a social security scheme * And between 14+0d and 21+6d weeks of gestation. Non inclusion Criteria: * Women under guardianship, curators, deprived of liberty or under court protection, * With a history of recurrent miscarriage, * Presenting a multiple pregnancy, * Hemoglobinemia \<9g/dL or symptomatic anemia, * Presenting eating disorders or a BMI ≤ 18.5 or a BMI ≥ 40, * With orthopedic limitations, * Presenting cardiovascular or pulmonary disease, * Uncontrolled thyroid disease, * Presenting a high level of smoking, * With significant health problems, * Premature rupture of membranes, * Premature labor during this pregnancy or a history of at least 2 premature births, * Persistent vaginal bleeding, * Cervical incompetence, * Evidence of intrauterine growth restriction, * Uncontrolled epilepsy, * Diabetes (previous or gestational, diagnosed in the 1st trimester) or chronic hypertension, * Or having a planned home birth.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnant woman are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pregnant woman

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de Clermont-Ferrand

    RECRUITING

    Clermont-Ferrand, 63000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.